Elevated surface La promotes hyperfusion and contributes to impaired resorption in osteopetrosis

Area of Science:

• Skeletal Biology
• Cell Biology
• Pathology

Background:

• The skeleton is dynamic tissue responding to biomechanical loads.
• Osteoclasts, multinucleated cells, sculpt bone in conjunction with local cellular partners.
• Dysfunctional osteoclasts cause skeletal pathologies like osteopetrosis, characterized by impaired bone resorption.

Purpose of the Study:

• To identify and address molecular defects in osteoclast formation and function in osteopetrosis.
• To investigate the role of La in osteoclast fusion and resorptive activity.
• To develop a therapeutic strategy targeting osteoclast hyperfusion in autosomal recessive osteopetrosis.

Main Methods:

• Analysis of molecular dysfunction in murine and human osteopetrosis models.
• Investigating the surface expression of La in osteoclasts lacking SNX10 or OSTM1.
• Utilizing inhibitory antibodies to target excessive La surface function.

Main Results:

• Loss of SNX10 or OSTM1 leads to elevated surface La on osteoclasts.
• Inhibitory antibodies against La suppressed osteoclast hyperfusion in mutant osteoclasts.
• Therapeutic intervention restored osteoclast resorptive function in osteopetrosis models.

Conclusions:

• Osteoclast fusion is a critical regulator of bone resorption and a potential therapeutic target.
• Targeting excessive La surface function offers a promising strategy for treating osteopetrosis.
• This study provides proof-of-principle for therapeutic intervention in diseases of osteoclast dysfunction.